Relationship between biochemical markers and radiographic scores in the evaluation of the osteoarticular status of Warmblood stallions

Establishing the osteoarticular status of the horse is often performed by means of radiological screening of the animals. Widespread blood sampling could reveal to be an interesting alternative to this procedure which is time consuming and sometimes technically difficult. The aim of this study was to investigate the relationship between the radiological status of the horses and the levels of biochemical markers of cartilage degradation and synovial inflammation. A specific radiological scoring and classification system was therefore developed and applied on 63 stallions presented for studbook admission. Additionally, groups of horses were established according to the occurrence of osteochondrosis, degenerative joint disease and distal interphalangeal joint effusion. Insulin growth factor-I, myeloperoxidases, Coll2-1 and Coll2-1NO₂ were used as blood markers. The combination of the blood parameters did not seem to correlate with the used scoring system. Coll2-1NO₂ levels however tended to increase with poorer radiological class and this could therefore potentially be a useful predictor of the osteoarticular status in the horse. Coll2-1 levels were significantly higher in the degenerative joint disease group. A high percentage of horses with distal interphalangeal joint effusion was present in this study and was associated with decreased IGF-I and increased Coll2-1 levels.     

Plasma Concentration of Insulin-like Growth Factor I (IGF-I) in Growing Ardenner Horses Suffering from Juvenile Digital Degenerative Osteoarthropathy

Degenerative osteoarthropathy resulting in a reduced active lifespan was observed in Ardenner horses. In the context of joint biology, insulin-like growth factor I (IGF-I) is a potential candidate to affect the anabolism of cartilage matrix molecules. A group of 30 Ardenner horses reared under standardized conditions from weaning were evaluated periodically from 15 to 28 months of age to detect the early manifestations of the disease. At the end of this period, horses were classified in two pathological groups related to the degree of interphalangeal degenerative osteoarthropathy based on clinical and radiographic evaluations: healthy (46.7%) and pathological (53.3%) horses. Seven sequential blood samples were taken from each horse (during the evaluation period) to study the variation of IGF-I plasma concentration. We tested the variations of the IGF-I plasma concentration during growth, and the effect of sex and of pathological classes. Significant variations were observed during the research period, with a maximum value corresponding to spring and a minimum in autumn. A significant reduction of the IGF-I plasma concentration was also observed in the pathological horses (433.5 +/- 19.5 ng/ml) compared to the healthy horses (493.9 +/- 18.2 ng/ml). An alteration in the level of this growth factor could induce a disregulation of the mechanisms involved in the local control of joint and bone tissue development.     

Growth Rates in Thoroughbred Horses Raised in Florida

SummaryGrowth rates of thoroughbred horses are not as well defined as those of other farm animals, and only a few articles summarize growth of thoroughbred horses over a prolonged period. Body weight (BW), heart girth (HG), wither height (WH), body length (BL), and hip height (HH) of 128 thoroughbred horses (59 colts and 69 fillies) were recorded from birth to 15 months of age at 14- or 28-day intervals. Data were obtained from consecutive 20 foal crops. At birth (0 day), BW was 53.55 ± 5.20 kg (range, 39.04–67.19), HG was 0.82 ± 0.03 m (range, 0.75–0.90), WH was 1.02 ± 0.03 m (range, 0.93–1.10), BL was 0.74 ± 0.03 m (range, 0.67–0.82), and HH was 1.05 ± 0.03 m (range, 0.93–1.14). At weaning (112 ± 3 days), BW was 199.57 ± 13.58 kg (range, 163.44–234.26), HG was 1.29 ± 0.04 m (range, 1.19–1.37), WH was 1.27 ± 0.03 m (range, 1.21–1.35), BL was 1.17 ± 0.03 m (range, 1.08–1.30), and HH was 1.32 ± 0.03 m (range, 1.24–1.39). At 6 months (181 ± 4 days), BW was 237.16 ± 18.48 kg (range, 186.14–288.74), HG was 1.36 ± 0.04 m (range, 1.24–1.45), WH was 1.33 ± 0.03 m (range, 1.26–1.40), BL was 1.25 ± 0.03 m (range, 1.17–1.33), and HH was 1.38 ± 0.03 m (range, 1.28–1.44). At 12 months (361 ± 8 days), BW was 337.73 ± 26.61 kg (range, 267.86–394.98), HG was 1.56 ± 0.05 m (range, 1.41–1.66), WH was 1.45 ± 0.03 m (range, 1.36–1.55), BL was 1.42 ± 0.04 m (range, 1.31–1.51), and HH was 1.49 ± 0.03 m (range, 1.41–1.57). At 15 months (447 ± 8 days), BW was 392.48 ± 30.61 kg (range, 317.80–457.18), HG was 1.64 ± 0.05 m (range, 1.52–1.76), WH was 1.49 ± 0.03 m (range, 1.42–1.58), BL was 1.48 ± 0.04 m (range, 1.40–1.59), and HH was 1.53 ± 0.03 m (range, 1.46–1.62). Two regression equations (y₁ from birth to 112 days of age and y₂ from 113 to 450 days of age) were calculated. WT_kg is estimated by y₁ = 1.28x + 57.82 (R² = 0.94) and y₂ = 0.57x + 133.28 (R² = 0.86). HG_m is estimated by y_l = 0.0041x + 0.86 (R² = 0.90) and y₂ = 0.0011x + 1.16 (R² = 0.84). WH_m is estimated by y₁ = 0.0022x + 1.03 (R² = 0.85) and y₂ = 0.0006x + 1.22 (R² = 0.80). BL_m is estimated by y₁ = 0.0038x + 0.77 (R² = 0.92) and y₂ = 0.0009x + 1.09 (R² = 0.85). HH_m is estimated by y₁ = 0.0024x + 1.07 (R² = 0.87) and y₂ = 0.0006x + 1.27 (R² = 0.78).     

Coll2-1, Coll2-1NO<Subscript>2</Subscript> and myeloperoxidase concentrations in the synovial fluid of equine tarsocrural joints affected with osteochondrosis

The measurement of biomarkers that reflect cartilage breakdown is a powerful tool for investigating joint damage caused by disease or injury. Particularly in cases of osteochondrosis, synovial concentrations of these biomarkers may reveal the presence of osteoarthritic changes. Coll2-1, Coll2-1 NO₂ and myeloperoxidase have recently been introduced in equine osteoarticular research but comparison between the concentrations of these markers in OCD affected and healthy joints has not been made. Therefore, this study aimed at reporting the synovial concentrations of these biomarkers in joints affected with osteochondral fragments in the tarsocrural joint compared to unaffected joints. Myeloperoxidase and Coll2-1NO₂ revealed to have similar levels between affected joints and controls. However, in contrast to previous studies using C2C the present study demonstrated that synovial levels of Coll2-1 were significantly elevated in tarsocrural joints affected with osteochondrosis. Thus, Coll2-1 may be an earlier marker of cartilage degeneration than other cartilage degradation markers that have been previously used in equine medicine.     

Histologic Evaluation of Palmar Digital Nerves after Perineural Injection of 2% Ammonium Chloride in Miniature Horses

Neurolytic compounds are widely used by equine practitioners for the management of lameness, mostly related to the foot. The present study aimed to evaluate the neurotoxicity of 2% ammonium chloride (2% AC) applied adjacent to the palmar digital nerves in six miniature horses. The 2% AC and 0.9% saline solution were randomly injected into three and one palmar digital nerve of each horse, respectively. Nerve samples were collected by neurectomy performed under general anesthesia at 5, 12, 19, 35, 47, and 62 days after treatment, with one horse per day of surgery. The inflammatory reaction to perineural injection was evaluated by an increase of pastern superficial skin temperature through thermography 24 hours after treatments. Histological lesions were classified as absent, mild, moderate, and severe Wallerian degeneration. An increase of 2.43 ± 0.79°C and 1.69 ± 0.55°C was observed in the 2% AC and control groups, respectively (P > .05). Moreover, histologic lesions were observed after perineural injection of 2% AC (severe, n = 5/18; moderate, n = 4/18; mild, n = 5/18; and absent, n = 4/18) and saline solution (moderate, n = 3/6; mild, n = 1/6; and absent, n = 2/6) (P = .46). The 2% AC demonstrated to be as safe as 0.9% saline solution, producing mild to severe Wallerian degeneration for up to 62 days after injection with no interference in further neurectomy.     

Radiographic evolution of the forelimb digit in Ardenner horses from weaning to 28 months of age and its clinical significance

Ossification of collateral cartilages is a common radiographic finding in draught horses and indication of a high frequency of interphalangeal osteo-arthropathy have been found in Ardenner horses. This study first aimed at following the evolution of the digits of the forelimbs on radiographic images in a group of 32 Ardenner horses from weaning to 852 +/- 19 days and, secondly, at evaluating the clinical significance of the observed radiographic changes. At 250 +/- 21 days, only 23% of the horses presented a small separate ossification centre of collateral cartilages above the level of the distal sesamoid bone or at the level of the proximal half of the middle phalanx. At 852 +/- 19 days, 100% of the horses presented an ossification of collateral cartilages but at different stages and grades. The presence and the extent of the ossification of the lateral cartilages were not significantly associated with lameness. Phalanges changes appeared at the average age of 1 year and they were represented by entheseophytes on the dorsal surface of the middle and distal phalanges. The frequency of affected horses increased with age as well as the size of the entheseophytes. This may reflect mechanical stresses applied to the interphalangeal joints. A significant association with the presence of lameness was pointed out. The presence and the severity of phalanges changes could be of importance, in combination with a clinical examination, in improving the selection of horses able to assume work and/or leisure activities.     

Evaluation of Propofol as a General Anesthetic for Horses

This study provides baseline information on the potential use of propofol as a general anesthetic for horses. Using a Latin square design, propofol (2, 4, and 8 mg/kg) was administered intravenously on three separate occasions to six mature horses. Information about anesthetic induction, duration, and recovery was recorded along with results of rectal temperature, heart rate, respiratory rate, pHa, Paco₂ and Pao₂. Statistical analysis included a mixed model analysis of variance, a general linear model analysis and least square means test for post hoc comparisons. A P <.05 was considered significant. The quality of induction of anesthesia varied from poor to good. Two horses were not recumbent following the lowest dose of propofol. Brief paddling limb movements occurred occasionally and unpredictably after recumbency induced by all three doses. During recovery, horses were uniformly calm and coordinated in their moves to stand. Duration of recumbency (minutes) was dose related; 15.05 ± 1.58 (±±SD) following 2 mg/kg, 31.06 ± 5.56 following 4 mg/kg, and 47.85 ± 13.63 following 8 mg/kg. During recumbency at all doses, heart rate significantly increased from a predrug value of 40 ± 6 beats per minute. Substantial respiratory depression, characterized by a significant decrease in respiratory rate (from 11.7 ± 2.9 to 3.7 ± 1.6 breaths per minute) and increased Paco₂ (from 44.5 ± 2.5 to 52.7 ± 8.0 mm Hg) was seen only after 8 mg/kg. A significant decrease in Pao₂ was observed throughout the recumbency induced by 8 mg/kg, and also at 3 and 5 minutes following induction of anesthesia with 4 mg/ kg propofol. At 5 minutes after injection, Pao₂ was 87.4 ± 13.8 and 58.1 ± 17.0 mm Hg after 4 and 8 mg/kg, respectively. The results of this study do not favor the routine use of propofol as a sole anesthetic in otherwise unmedicated horses.     

Thoracoscopic Lung Biopsies in Heaves‐Affected Horses Using a Bipolar Tissue Sealing System

Objective: To validate the use of the LigaSure? Vessel Sealing System (LVSS) to perform thoracoscopic lung tissue biopsies in heaves‐affected horses. Study design: Prospective clinical study. Animals: Heaves‐affected horses (n=12). Methods: Lung biopsies (n=34) were collected with the LVSS (2–4 biopsies/horse) in horses with and without clinical signs of heaves. Thoracoscope (13th intercostal space [ICS]) and 2 instruments (between the 12–15th ICS) portals were used. Selected clinical and arterial blood gas variables were monitored. Postoperative pneumothorax was evaluated. Depth of thermal injury to the surrounding tissue and representativeness of the biopsies were determined. Results: Mean surgical time was 22.9±8.0 minutes. The complication rate was 5.6%, and primarily related to a focal inadequate sealing of the biopsy margin. Five horses in exacerbation required intraoperative intranasal O₂. Mean PaO₂ was significantly lower in heaves‐affected horses with clinical signs compared with those without clinical signs. Postoperative pneumothorax was detected radiographically after 20 of the 34 procedures. One horse with clinical signs of heaves developed a fatal tension pneumothorax 5 days postoperatively despite close radiographic monitoring. Conclusion: Thoracoscopic lung biopsy using LVSS is a rapid and effective technique to harvest peripheral lung tissues from heaves‐affected horses. Although the complication rate was tolerable, tension pneumothorax was a potential life‐threatening complication because of incomplete lung sealing. Clinical Relevance: LVSS can be used with relative safety to perform thoracoscopic lung biopsy, but close postoperative monitoring is necessary to avoid tension pneumothorax.     

Serum Amyloid A (SAA) Concentration after Vaccination in Horses and Mules

Serum amyloid A (SAA) is a sensitive acute-phase response (APR) marker in equids. Prominent APRs with elevations of SAA concentrations ([SAA]) have been reported after vaccination. The authors hypothesized that vaccination with an inactivated EHV-1/-4 vaccine would cause increase in [SAA] and antibody responses and that higher [SAA] would be positively correlated with the antibody titer in both equids. Twelve Haflinger horses and 12 mules were included in this longitudinal prospective study. All horses and mules were vaccinated with a commercially available EHV-1/-4 vaccine. Blood was sampled before and after vaccination to measure [SAA] and virus-neutralizing response (VN-T). In horses and mules, significantly higher [SAA] were measured on days 1, 3, and 5 after EHV-1/-4 vaccination; [SAA] on day 1 after vaccination were only measured in animals that developed fever, where mean [SAA] were significantly higher in horses than in mules (horses: 1,365.75 ± 87.64 mg/L, mules: 615.5 ± 153.444 mg/L) (P > .05). Four horses and 2 mules developed fever after vaccination, lasting for ≤24 hours. Increased antibody responses (VN-T) on days 7 and 14 after vaccination were observed in all animals, whereas mules showed higher overall antibody responses. Nevertheless, [SAA] did not correlate with the intensity of the antibody responses (VN-T) stimulated by the vaccine (P < .05). EHV-1/-4 vaccination caused a prominent APR, higher in horses than in mules, but [SAA] did not correlate with antibody responses. Measuring [SAA] after vaccination could help identify severe APRs that may require longer resting intervals before training or competition.     

A Preliminary Study Examining the Digital Cushion in Horses

The digital cushion is important for the dissipation of impact as the foot contacts the ground. If there is inefficient energy dissipation, potential exists for changes to occur in the foot. Although ultrasonic imaging of the digital cushion has been reported, it is unknown if these measurements account for compositional changes that have been reported across age, breed, and between fore and hind feet. Therefore, the objective of this preliminary study was to establish baseline values in mature, stock type horses with adequate body condition score (BCS). To meet this objective, 24 mature, stock-type horses of similar age, height, and weight were used to establish baseline values for the digital cushion thickness in the live horse. All horses were sound at the time of data collection and had no known history of long-term lameness conditions. Digital cushion thickness of the left fore and left hind foot was determined using ultrasound through the transcuneal approach. Data were analyzed using the PROC MEANS and PROC GLM procedure of SAS with a least square means statement. Significance was set at P ≤ .05. Mean values (±standard error [SE]) for age, weight, height, and BCS were 10.7 ± 0.86 years, 476.2 ± 7.75 kg, 153.56 ± 0.90 cm, and 5.6 ± 0.12, respectively. Mean values (±SE) for the digital cushion of the left fore and left hind were 0.96 ± 0.03 and 1.02 ± 0.04 cm, respectively. When comparing the left fore and left hind, there was no significant difference observed. Overall, baseline values of digital cushion thickness for fore and hind feet were established, allowing for future studies to assess the different variables known to affect digital cushion composition.     

Evaluation of serum osteocalcin and CTX-I in Ardenner horses with special reference to juvenile interphalangeal joint disease

The first aim of this study was to establish a profile of age-related normal serum concentrations of osteocalcin (OC) in Ardenner horses. For this first part, blood samples from 49 healthy Ardenner horses were collected. The second aim was to study two biochemical markers of bone metabolism, OC and a carboxy-terminal cross-linking telopeptide of type I collagen (CTX-I), in 30 young Ardenner horses during 1 year. Amongst them, 17 showed lesions of juvenile degenerative joint disease in the distal forelimbs. A specific radioimmunoassay for equine OC was used to measure the serum concentration of the marker. The serum concentration of CTX-I was measured using a commercially available human assay validated for use in the horse. The effect of age, sex, season and health status (with or without lesions) was assessed. Levels of OC fall between birth and the adult stage: this decrease being most marked between birth and 1 year of age. This age-related decrease of OC was confirmed in the 30 young Ardenner horses, but CTX-I levels remained constant in this group. The Levels of the two markers changed significantly with the season with higher concentrations during the winter. No significant difference was shown either between the two sexes or between the two health statuses.     

Training Program Intensity Induces an Acute Phase Response in Clinically Healthy Horses

Physiological and hematochemical changes associated with exercise have been extensively investigated in equine species. It is known that stress elevates circulating levels of acute phase proteins (APPs). This survey evaluated whether horses trained with different training programs exhibit changes in APP levels after exercise event. Twenty Saddle Italian horses (11 geldings and 9 females, 9 ± 1 years old, body weight of 425 ± 35 kg) were divided into two equal groups according to the intensity of training programs they were subjected: group A was subjected to an intense training program, group B was subjected to a moderate training program. At the end of the training period, horses were subjected to a simulated exercise event (show jumping course of 400 m length with 12 obstacles). From horses, blood samples were collected at rest conditions (T_REST) and after 12 and 24 hour from the end of exercise (T_{12 h} and T_{24 h}); the concentration of serum amyloid A (SAA), haptoglobin, albumin, total proteins, iron, and fibrinogen was assessed. The circulating levels of SAA, fibrinogen, and iron were influenced by simulated exercise event (P < .01), starting from 12 hour after the end of exercise, suggesting the onset of an acute phase–like response, and it would seem that training program intensity the horses underwent also affected the degree of response, although only SAA values were significantly different between groups (P < .001). The findings obtained suggest that jumping exercise induces an acute phase response; however, further studies are advocated to better evaluate mechanisms by which exercise activates this response in the athletic horse.     

Comparison of Nutrient Digestibility Between Adult and Aged Horses

There is little published work comparing digestibility in healthy adult versus healthy aged horses. Researchers hypothesized that there would be no differences in macronutrient digestibility between eight adult (5–12 years) and nine aged (19–28 years) horses fed three diets in a Latin square design. Seventeen stock-type mares were randomly assigned for a 5-week period to one of three diets: hay only (HAY), hay plus a starch- and sugar-rich concentrate (CHO), or hay plus a fat- (oil) and fiber-rich concentrate (FF). Each diet period comprised 3 weeks of outdoor group drylot feeding, 2 weeks of indoor stalled individual feeding, followed by a 72-hour digestibility trial including total urine and fecal collection. Feed, fecal, and/or urine samples were analyzed to determine dry matter, crude protein, fat, energy, calcium, and phosphorus apparent retention as well as apparent digestibility. Neutral detergent fiber digestibility was also determined. Mean body weight was lower in aged than in adult horses (455 ± 12 kg vs. 500 ± 13 kg; P = .02), but body condition score (BCS) did not differ between groups (aged horses, 4.8 ± 0.2 BCS and adult horses, 5.1 ± 0.2 BCS; P = .20). No age differences in digestibility, apparent digestibility, or apparent retention were seen for any of the variables measured. Based on the results of this study, total tract macronutrient digestibility appears to be similar between healthy adult and aged horses.     

Effects of Intravenous Detomidine on Schirmer Tear Test Results in Clinically Normal Horses

This study was conducted to determine the effects of intravenous detomidine on Schirmer tear test (STT) results in clinically normal horses. Eighteen adult horses were randomly divided into two groups of nine horses each. The treatment group was sedated with intravenous detomidine alone (20 μg/kg), and the control group received only intravenous saline (0.2 mL/100 kg). Schirmer tear test was performed just before intravenous administration of detomidine or saline in treatment and control groups, respectively. Schirmer tear tests were repeated 5, 20, 60, and 120 minutes later. Horses enrolled in this study consisted of nine males and nine females. Breeds were Arabian and Hanoverian, ranging from 3 to 6 years in age. In the treatment group, the pretreatment and subsequent posttreatment mean ± standard deviation values were 17.0 ± 6.9 (0 minutes), 11.8 ± 2.9 (5 minutes), 12.1 ± 2.0 (20 minutes), 12.1 ± 3.1 (60 minutes), and 15.0 ± 2.8 (120 minutes) mm wetting/min. In this group of horses, a significant reduction was observed in STT values at 5, 20, and 60 minutes after treatment with detomidine hydrochloride in comparison to the pretreatment values (analysis of variance with post hoc testing; P₅ = 0.004, P₂₀ = 0.007, P₆₀ = 0.006). There was no significant difference between baseline values and posttreatment values in the control saline group (P ≥ .08). We conclude that intravenous detomidine causes a significant reduction in STT values in clinically normal horses. In horses, practitioners should measure STT values before intravenous administration of detomidine to accurately assess the results.     

Preemptive Analgesia,Including Morphine,Does Not Affect Recovery Quality and Times in Either Pain-Free Horses or Horses Undergoing Orchiectomy

Recovery quality and times from general anesthesia in horses may be influenced by surgery, analgesia with morphine or combinations of both. Twenty-three adult healthy horses were enrolled in this prospective experimental trial in a clinical setting and were randomly allocated to one of the following groups: anesthesia only (GA; n = 6), preemptive analgesia and anesthesia (GAA; n = 5), anesthesia and castration (GC; n = 6), or preemptive analgesia, anesthesia, castration, and intraoperative local analgesia (GCA; n = 6). All horses were sedated with intramuscular (IM) xylazine (0.5 mg/kg). Anesthesia was induced with intravenous (IV) guaifenesin (100 mg/kg) and thiopental (5 mg/kg) and maintained with isoflurane in oxygen. Animals in groups with preemptive analgesia received IM morphine (0.2 mg/kg) and dipyrone (10 mg/kg) and IV flunixin meglumine (1.0 mg/kg) immediately before sedation. Recoveries from general anesthesia were rope-assisted. Recovery scores (from 8 [excellent recovery] to 70 [worst recovery]) and times were compared between groups, using a one-way analysis of variance followed by a Tukey's test (P < .05). Mean ± standard deviation (SD) and range recovery scores were 22 ± 14 (8–45), 9 ± 2 (8–12), 14 ± 5 (8–22), and 12 ± 1 (10–13) in groups GA, GAA, GC, and GCA, respectively. Mean ± SD times to stand in minutes were 21 ± 10, 18 ± 7, 33 ± 12, and 35 ± 21 in groups GA, GAA, GC and GCA, respectively. No statistically significant differences were found for any of the variables. Neither preoperative administration of analgesics, including morphine, nor castration interfered with the recovery qualities and times in horses undergoing general anesthesia. Preemptive morphine did not worsen anesthetic recovery quality in horses.     

Increased Inflammatory Mediators in Horses Naturally Infected with Trypanosoma vivax. A Preliminary Study

The aim of this study was to measure the levels of inflammatory mediators in serum from horses naturally infected with Trypanosoma vivax. Banked serum samples collected during a previously reported T. vivax natural infection were used to analyze proinflammatory cytokines such as interferon-gamma (IFN-γ), tumor necrosis factor-alpha (TNF-α), interleukin 1 (IL-1), interleukin 6 (IL-6), and nitrite/nitrate (NO_x) levels. We evaluated 12 serum samples from horses from a farm in southern Brazil, four of which had parasitological and molecular diagnoses for T. vivax and presented with clinical signs of disease. Cytokines were assessed by quantitative sandwich enzyme-linked immunosorbent assay, and NO_x was measured using the modified Griess method. Levels of IFN-γ, TNF-α, IL-1, IL-6, and NO_x were increased in serum of infected animals compared to that in noninfected animals. Therefore, infection with T. vivax caused an increase in proinflammatory cytokines and nitric oxide content.     

Experimental Leptospira interrogans Serovar Kennewicki Infection of Horses

Background: Little information is available about experimental induction of leptospirosis in horses. Objectives: Determine serologic, hematologic responses of horses to Leptospira interrogans serovar Kennewicki infection. Animals: Four adult horses seronegative for leptospirosis. Methods: Experimental and observational study. Horses were challenged with an equine isolate of L. interrogans serovar Kennewicki at 2 different doses and different inoculation sites. After challenge, the horses were monitored for 60 days. Blood, urine, and aqueous humor samples were collected at intervals until euthanasia 60 days after infection. Results: Pyrexia (39.3–40°C) occurred as early as 1 day after challenge with 10 × 10⁸Leptospira divided equally between topical ocular and intraperitoneal injection in 2 horses. Leptospires were recovered from the blood and urine but not from the aqueous humor of the 2 febrile horses. The sera of all 4 challenged horses developed microscopic agglutination test antibody after challenge and remained relatively constant for 21 days. Titer to cross‐reacting strains declined earlier than titer to the challenge strain. Conclusions: Clinical disease in experimentally infected horses can be mild or inapparent in Leptospira infected horses. Repeated serologic testing can allow recognition of the infecting serovar. In febrile horses, Leptospira can be isolated from blood while isolation from the urine can occur after fever has subsided.     

Retrospective study on 30 horses with chronic proliferative pododermatitis (canker)

The medical records of 30 horses (18 Warmbloods, 7 draught horses, 3 other breeds and 2 of unknown origin) with chronic proliferative pododermatitis (canker) were reviewed and long‐term outcome was obtained by telephone questionnaire. In 28/30 cases, the owner was the first to discover the problem. The disease was initially recognised as canker in only 5/28 cases, whereas in 10/28 cases a treatment for thrush had been continued for several months before referral. There was a similar prevalence in the fore (41) and hind (44) hooves; 13/30 horses had 4 hooves affected. Treatment consisted of surgical debridement and hoof care. Duration of hospitalisation was significantly decreased in horses receiving oral prednisolone for 3 weeks compared to those without this additional systemic treatment (mean ± s.d. 24 ± 5 days, n = 7 vs. 40 ± 19 days, n = 19, respectively). Long‐term follow‐up ranged from 3 months to 6 years (36 ± 22 months) and was available for 24 horses. No recurrence was reported in 10 horses. In 14 horses problems recurred within the first year, and 6 had been subjected to euthanasia for this reason specifically, whereas the others were managed by regular trimming. There was no significant association between recurrence and the number of affected hooves or the use of any systemic treatment. Horses with delayed referral because of preceding treatments had significantly more chance to develop recurrence, highlighting the need for prompt diagnosis and subsequent treatment.     

A type II-collagen derived peptide and its nitrated form as new markers of inflammation and cartilage degradation in equine osteochondral lesions

Markers of cartilage breakdown enable studying the degradation of cartilage matrix in equine joint pathologies. This study was designed to determine the levels of Coll2-1, a peptide of the triple helix of type II collagen, and Coll2-1NO(2), its nitrated form in the plasma of healthy horses (controls; n=37) and horses suffering from osteochondrosis (n=34). Clinical and arthroscopic scores were attributed reflecting the severity of lesions and were related to the plasma levels of Coll2-1 and Coll2-1NO(2). The median of Coll2-1 was significantly higher in the control group, whereas the mean of Coll2-1NO(2) showed significant elevation in the pathological group. However, the measurement means of scoring classes did not vary significantly. The markers were able to differentiate the group of horses suffering from osteochondrosis from the group of healthy horses. The elevation of Coll2-1NO(2) in the pathological group indicates an inflammation, mediated through reactive oxygen species and/or increased myeloperoxidase activity.     

Sex differences in the response of yearling horses to handling by unfamiliar humans

In adult horses, pronounced sex differences in behavior exist, and many riders prefer male horses to mares. In the present study, we tested the hypothesis that sex differences in the response of horses to handling emerge before puberty, that is, in sexually immature animals. Warm-blooded yearling horses (6 males and 9 females) were exposed to a stationary human test (exposure to an unfamiliar person for 5 minutes) and a tolerance test (haltering and direct contact with the horse) on 5 consecutive days. The horses' behavior and heart rate were recorded. Male yearling horses displayed significantly less exploratory behavior than females during the stationary human test on days 1 and 2 (P < 0.05). Latency to halter and ease with which horses could be haltered were significantly affected by day (P < 0.05), and a significant interaction of day and sex was detected (P < 0.05; e.g., time for haltering: females, day 1: 23.8 ± 7.8 seconds [±standard error of the mean] and day 5: 21.1 ± 1.7 seconds; males, day 1: 53.6 ± 10.4 seconds and day 5: 19.4 ± 2.2 seconds). Heart rate of the horses in response to the test situations was significantly affected by day (P < 0.01) but not by sex. In conclusion, sex differences in behavior do not only exist in adult horses but are already present in young horses before puberty. When exposed to unfamiliar humans for the first time, male yearling horses display more caution than females.